Evidence map›Paper›PMID 40562249›Full record

ArticleJournal of clinical epidemiology2025

Effect of pre-end-stage kidney disease nephrology care on the association between neighborhood poverty and referral for kidney transplantation among patients with end-stage kidney disease.

Laura McPherson, Laura C Plantinga, Penelope P Howards, Michael Kramer, Rachel E Patzer

Abstract read
In one paragraph

Article in Journal of clinical epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Medicaid Expansion and Optimal Starts of Treatment for Incident Kidney Failure.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura McPhersonDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Center for Research and Evaluation, Kaiser Permanente Georgia, Atlanta, GA, USA. Electronic address: laura.m.mcpherson@kp.org.
Laura C PlantingaDivision of Rheumatology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Penelope P HowardsDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Michael KramerDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Rachel E PatzerDivision of Transplantation, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA; Regenstrief Institute, Indianapolis, IN, USA.

Funding

Reducing Racial Disparities in Access to Kidney Transplantation: the RaDIANT Regional StudyU01MD010611 · NIMHD · EMORY UNIVERSITY · PI PATZER, RACHEL E · 2016 to 2020
$2.8M
Improving Quality and Access to Early Steps in Kidney TransplantationR01DK122701 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI PASTAN, STEPHEN, PATZER, RACHEL E · 2019 to 2022
$2.5M
Early Access to Kidney Transplantation among Patients with Lupus NephritisF31DK135379 · NIDDK · EMORY UNIVERSITY · PI MCPHERSON, LAURA · 2023 to 2024
$71k
NIDDK NIH HHS F31 DK135379NIDDK NIH HHS R01 DK122701NIMHD NIH HHS U01 MD010611
6 · The paper itself

Abstract

objectivesSocioeconomic inequities in early access to kidney transplantation among patients with end-stage kidney disease (ESKD) are well documented. It is unknown whether these inequities can be mitigated through access to nephrology care prior to starting dialysis. This study evaluated whether pre-ESKD nephrology care meaningfully explained the association between neighborhood poverty and referral for kidney transplantation among patients initiating treatment for ESKD. STUDY DESIGN AND

settingIn this retrospective cohort study using United States Renal Data System data (January 1, 2012 to June 30, 2021), we identified 192,318 adults with incident ESKD from dialysis facilities in Southeast, Northeast, New York, and Ohio River Valley US regions. Neighborhood poverty exposure was dichotomized based on zip code poverty rates (≥20% vs 0%-19%), and referral outcomes were assessed from 28 transplant centers. We used marginal structural Cox models with inverse probability of treatment weighting to estimate the direct effect of neighborhood poverty on referral for kidney transplantation, controlling for access to pre-ESKD nephrology care (controlled direct effect).

resultsFindings show that 68% had pre-ESKD nephrology care, and 25% lived in high-poverty areas. Pre-ESKD nephrology care was associated with increased referral (hazard ratio (HR): 1.26, 95% CI: 1.22, 1.30). Adjusted analyses using marginal structural Cox models with inverse probability weighting revealed that pre-ESKD nephrology care did not fully explain the association between neighborhood poverty and referral for kidney transplantation (controlled direct effect HR: 0.87, 95% CI: 0.85, 0.89; total effect HR: 0.90, 95% CI: 0.88, 0.91).

conclusionThese results underscore the beneficial role of pre-ESKD nephrology care in enhancing transplant referral access. However, persistent disparities linked to neighborhood poverty remain evident. The study emphasizes the continued importance of pre-ESKD nephrology care as a clinical standard for all patients with ESKD. Future research should explore interventions earlier in the kidney disease continuum to address socioeconomic disparities and improve equitable access to kidney transplantation. PLAIN LANGUAGE SUMMARY: For people with end-stage kidney disease (ESKD), survival depends on either regular dialysis treatments or a kidney transplant. For most people, a kidney transplant offers the best long-term survival and quality of life compared to dialysis. People living in poorer neighborhoods face significant challenges in getting referred for a kidney transplant. Our study aimed to investigate if receiving care from a kidney specialist (nephrologist) before needing dialysis (pre-ESKD nephrology care) could help overcome these income-related disparities in transplant access. We looked at records from nearly 200,000 adults across 4 US regions who started treatment for ESKD. We categorized neighborhoods as "high-poverty" (where 20% or more residents live below the poverty line) or "low-poverty" areas. Using advanced statistical methods, we analyzed how neighborhood poverty affected transplant referral, specifically assessing the role of pre-ESKD nephrology care. Our findings showed that most patients (68%) had seen a nephrologist before dialysis. Seeing a nephrologist was associated with a 26% higher chance of being referred for a transplant. However, even among those who received predialysis nephrology care, living in a high-poverty neighborhood still meant they were 13% less likely to be referred for a transplant. This study highlights that while pre-ESKD nephrology care is beneficial and increases the likelihood of transplant referral, it alone does not fully close the gap in access influenced by neighborhood poverty. To achieve equitable access to kidney transplantation for all patients, future efforts must target broader interventions that address the underlying socioeconomic factors affecting health throughout a patient's kidney disease journey.

Indexed as

Healthcare DisparitiesKidney Failure, ChronicKidney TransplantationNeighborhood CharacteristicsNephrologyPovertyReferral and ConsultationAdultAgedFemaleHealth Services AccessibilityHumansMaleMiddle AgedRenal DialysisRetrospective StudiesEnd-stage kidney diseaseKidney transplantNeighborhood povertyNephrology careReferralSocioeconomic factors

Identifiers

PMID40562249
PMCPMC12798701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.